Format

Send to

Choose Destination
Protein Cell. 2019 May 27. doi: 10.1007/s13238-019-0638-8. [Epub ahead of print]

Modeling neuropsychiatric disorders using human induced pluripotent stem cells.

Author information

1
Laboratory of Genetics, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd, La Jolla, CA, 92037, USA.
2
Neurobiology Section, Division of Biological Sciences, University of California San Diego, La Jolla, CA, 92093, USA.
3
Laboratory of Genetics, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd, La Jolla, CA, 92037, USA. gage@salk.edu.

Abstract

Neuropsychiatric disorders are complex disorders characterized by heterogeneous genetic variations, variable symptoms, and widespread changes in anatomical pathology. In the context of neuropsychiatric disorders, limited access to relevant tissue types presents challenges for understanding disease etiology and developing effective treatments. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an opportunity to recapitulate disease development in relevant cell types, and they provide novel approaches for understanding disease mechanisms and for development of effective treatments. Here we review recent progress and challenges in differentiation paradigms for generating disease-relevant cells and recent studies of neuropsychiatric disorders using human pluripotent stem cell (hPSC) models where cellular phenotypes linked to disease have been reported. The use of iPSC-based disease models holds great promise for understanding disease mechanisms and supporting discovery of effective treatments.

KEYWORDS:

autism spectrum disorder; bipolar disorder; brain organoid; iPSCs; neuropsychiatric disorders; schizophrenia

PMID:
31134525
DOI:
10.1007/s13238-019-0638-8

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center